Author Archive

Men’s Health Week 2018 – Famous Men with Migraine

13th June 2018

Migraine can occur in just about anybody and it does not discriminate between genders, ages or socioeconomic status. Sometimes when celebrities speak up about their battles with migraine it can help to lift the stigma surrounding the condition and make the general population more aware of the chronically debilitating nature of the condition. For male celebrities, particularly sportsmen, admitting to a suffering from a condition that is often... [read more]


Patient Information Evening, Louth, 26th April

9th April 2018

This seminar is presented by Dr Raeburn Forbes - a practising neurologist from Northern Ireland and one of Ireland's leading migraine and headache experts. Dr. Forbes is author of The Billionaire's Book of Headaches and the accompanying free online headache self management course, an innovative online course to help you better understand and manage your migraines. "What you will read here is what I tell my own patients. Many people with... [read more]


Notice of AGM 2018

7th March 2018

Please note the Annual General Meeting of The Migraine Association of Ireland will take place on Monday, 23rd April at 5... [read more]


Call for posters for NAI Conference

9th January 2018

Poster presentations are invited on basic, clinical and social research into brain conditions to feature at the Neurological Alliance of Ireland & Irish Brain Council Joint Conference “Research & Healthcare Responses to the Challenge of Brain Conditions in Ireland” Science Gallery Dublin 6th March 2018. Applicants should aim to submit abstracts no later than Friday 9th February 2018 to brainresearch2018@gmail.com including contact... [read more]


New Drugs for Migraine on the Way

6th December 2017

Calcitonin gene-related receptor (CGRP) antagonists are the most important medications in advanced stage clinical development for the treatment of both the acute migraine attack and the prevention of frequent attacks. Clinical trials on two of the antibodies have now been published in the New England Journal of Medicine. One antibody, Erenumab made by Novartis, was trialed on 955 patients with episodic migraine. At the start of the... [read more]


Author Archive

Men’s Health Week 2018 – Famous Men with Migraine

13th June 2018

Migraine can occur in just about anybody and it does not discriminate between genders, ages or socioeconomic status. Sometimes when celebrities speak up about their battles with migraine it can help to lift the stigma surrounding the condition and make the general population more aware of the chronically debilitating nature of the condition. For male celebrities, particularly sportsmen, admitting to a suffering from a condition that is often... [read more]


Patient Information Evening, Louth, 26th April

9th April 2018

This seminar is presented by Dr Raeburn Forbes - a practising neurologist from Northern Ireland and one of Ireland's leading migraine and headache experts. Dr. Forbes is author of The Billionaire's Book of Headaches and the accompanying free online headache self management course, an innovative online course to help you better understand and manage your migraines. "What you will read here is what I tell my own patients. Many people with... [read more]


Notice of AGM 2018

7th March 2018

Please note the Annual General Meeting of The Migraine Association of Ireland will take place on Monday, 23rd April at 5... [read more]


Call for posters for NAI Conference

9th January 2018

Poster presentations are invited on basic, clinical and social research into brain conditions to feature at the Neurological Alliance of Ireland & Irish Brain Council Joint Conference “Research & Healthcare Responses to the Challenge of Brain Conditions in Ireland” Science Gallery Dublin 6th March 2018. Applicants should aim to submit abstracts no later than Friday 9th February 2018 to brainresearch2018@gmail.com including contact... [read more]


New Drugs for Migraine on the Way

6th December 2017

Calcitonin gene-related receptor (CGRP) antagonists are the most important medications in advanced stage clinical development for the treatment of both the acute migraine attack and the prevention of frequent attacks. Clinical trials on two of the antibodies have now been published in the New England Journal of Medicine. One antibody, Erenumab made by Novartis, was trialed on 955 patients with episodic migraine. At the start of the... [read more]